Research Square (preprint) · 2026
Clinical research · Istanbul
Birkan Alaycı, MD
Clinical Trials Unit, Koç University
Internal medicine specialist. I work on turning clinical questions into analysable research designs, synthesising evidence transparently and reproducibly, and keeping conclusions within what the data can support.
Currently
Clinical Trials Unit
Working on clinical trials at the Clinical Trials Unit, Koç University (September 2026 – ).
PhD in Molecular Oncology
İstinye University, Institute of Graduate Studies — PhD Programme in Molecular Oncology (2026 – ).
Evidence synthesis methodology
Traceable, reproducible workflows for systematic reviews and meta-analyses; open data and open code.
Research areas
- Clinical trials
- Evidence synthesis & meta-analysis
- Reproducible research
- Metabolic medicine & body composition
- Molecular oncology
Selected work
Cureus · 2025
When Trimethoprim-Sulfamethoxazole Turns Pernicious: Type 4 Renal Tubular Acidosis in a Diabetic Patient With Sjögren’s Syndrome
GitHub · open source
glp1-lbm-dxa-meta-analysis
Data and R code for the meta-analysis of DXA-measured lean and fat mass with GLP-1 and dual GIP/GLP-1 receptor agonists (phase 3 RCTs; PROSPERO CRD420261323497).
GitHub · open source
meta-analysis-automation-engine
Automation for scientific meta-analysis: PubMed API, NLP, PDF parsing, hallucination checks and reproducible-research infrastructure.